Edgewise Therapeutics, Inc.
EWTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001710072
In the last 90 days, Edgewise Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.82B in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Edgewise Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 95 | 1 | 85 | −9 |
| Shares | 69.5M | 150.4K | 68.4M | −906.0K (−1.3%) |
| Value | $538.8M | $1.17M | $392.2M | −$145.5M (−27.1%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Edgewise Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Investments, LP | 57,564 | $329.8K | 0.00% |
| Gsa Capital Partners LLP | 43,964 | $252.0K | 0.02% |
| Millennium Management LLC | 35,893 | $205.7K | 0.00% |
| SG Americas Securities, LLC | 18,698 | $107.0K | 0.00% |
| Corton Capital Inc. | 17,044 | $97.7K | 0.05% |
| Pale Fire Capital SE | 15,645 | $89.6K | 0.01% |
| XTX Topco Ltd | 11,952 | $68.5K | 0.01% |
| Two Sigma Advisers, LP | 10,200 | $58.4K | 0.00% |
| Quantbot Technologies LP | 2,700 | $15.5K | 0.00% |
Sold out (18)
Institutions that held Edgewise Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| MPM Oncology Impact Management LP | 712,798 | $5.52M |
| Bank of Montreal | 316,904 | $2.70M |
| ExodusPoint Capital Management, LP | 138,227 | $1.07M |
| Point72 Asset Management, L.P. | 107,100 | $830.0K |
| PDT Partners, LLC | 24,935 | $193.2K |
| Balyasny Asset Management LLC | 20,660 | $160.1K |
| Mariner, LLC | 18,211 | $141.1K |
| Jane Street Group, LLC | 15,438 | $119.6K |
| Susquehanna International Group, LLP | 11,735 | $90.9K |
| Virtu Financial LLC | 11,010 | $85.0K |
| Parallel Advisors, LLC | 296 | $2.29K |
| Allworth Financial LP | 221 | $1.71K |
| Advisor Group Holdings, Inc. | 169 | $1.31K |
| Lindbrook Capital, LLC | 154 | $1.19K |
| Group One Trading, L.P. | 100 | $775 |
| Financial Synergies Wealth Advisors, Inc. | 83 | $644 |
| Quadrant Capital Group LLC | 41 | $318 |
| CWM, LLC | 45 | $0 |
Not filed for Q3 2023 yet (1)
Institutions that held Edgewise Therapeutics, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Tekla Capital Management LLC | 150,418 | $1.17M |